45972C102

(CUSIP Number)
12/31/2025

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 26,300,000 shares of common stock issuable upon conversion of the issuer's Series C Convertible Redeemed Preferred Stock (2) Based on 528,209,538 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report on Form 10-K for the year ended December 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person:  (1) Includes 5,000,000 shares of common stock subject to vested stock options exercisable within 60 days of the date hereof and (ii) 5,040,000 shares of common stock issuable upon conversion of Series C Preferred Stock. (2) Includes (i) 2,189,697 shares of common stock and (ii) 2,000,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's father's, for which the reporting person shares investment control. (3) Includes (i) 562,884 shares of common stock and (ii) 350,000 shares of common stock issuable upon conversion of Series C Preferred Stock, in each case held by the reporting person's son, for which the reporting person shares investment control. (4) Based on 523,706,140 shares of common stock outstanding as of March 26, 2026 as reported in the issuer's Annual Report of Form 10-K for the year ended December 31, 2025.


SCHEDULE 13G



 
Kennerman Associates, Inc.
 
Signature:/s/ Kennerman Associates, Inc.
Name/Title:President
Date:05/14/2026
 
GROSSO CHRISTOPHER G
 
Signature:/s/ Christopher Grosso
Name/Title:Christopher Grosso
Date:05/14/2026